Eligibility Breast Cancer NCT00963209

Criteria
Description

Criteria

diagnosis of breast cancer
Description

Breast Carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0678222
hormone-sensitive breast cancer defined as > 10% estrogen receptor and/or > 10% progesterone receptor positivity by immunohistochemistry
Description

Breast Carcinoma Hormone Responsive | Estrogen receptor positive Percentage Immunohistochemistry | Progesterone receptor positive Percentage Immunohistochemistry

Data type

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C1512498
UMLS CUI [2,1]
C0279754
UMLS CUI [2,2]
C0439165
UMLS CUI [2,3]
C0021044
UMLS CUI [3,1]
C0279759
UMLS CUI [3,2]
C0439165
UMLS CUI [3,3]
C0021044
receiving treatment with tamoxifen citrate and must be eligible for exposure to higher doses
Description

Tamoxifen Citrate | Exposure to High dose

Data type

boolean

Alias
UMLS CUI [1]
C0079589
UMLS CUI [2,1]
C0332157
UMLS CUI [2,2]
C0444956
patient characteristics:
Description

Client Characteristics

Data type

boolean

Alias
UMLS CUI [1]
C0815172
no history of deep venous thrombosis or pulmonary embolism
Description

Exclusion Criteria | Deep Vein Thrombosis | Pulmonary Embolism

Data type

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0149871
UMLS CUI [3]
C0034065
no history of endometrial carcinoma
Description

Exclusion | Endometrial Carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2]
C0476089
no known history of vaginal bleeding, endometriosis, endometrial hyperplasia, endometrial hypertrophy, and/or polyps
Description

Exclusion Criteria | Vaginal Hemorrhage | Endometriosis | Endometrial Hyperplasia | Endometrial hypertrophy | Polyps

Data type

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C2979982
UMLS CUI [3]
C0014175
UMLS CUI [4]
C0014173
UMLS CUI [5]
C0858833
UMLS CUI [6]
C0032584
not pregnant or nursing
Description

Exclusion Criteria | Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0006147
no contraindication to tamoxifen citrate treatment
Description

Exclusion | Medical contraindication Tamoxifen Citrate

Data type

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0079589
no known allergy to midazolam or dextromethorphan
Description

Exclusion Criteria | Midazolam allergy | Hypersensitivity Dextromethorphan

Data type

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0570821
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0011816
prior concurrent therapy:
Description

Therapeutic procedure

Data type

boolean

Alias
UMLS CUI [1]
C0087111
see disease characteristics
Description

ID.12

Data type

boolean

Similar models

Eligibility Breast Cancer NCT00963209

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Breast Carcinoma
Item
diagnosis of breast cancer
boolean
C0678222 (UMLS CUI [1])
Breast Carcinoma Hormone Responsive | Estrogen receptor positive Percentage Immunohistochemistry | Progesterone receptor positive Percentage Immunohistochemistry
Item
hormone-sensitive breast cancer defined as > 10% estrogen receptor and/or > 10% progesterone receptor positivity by immunohistochemistry
boolean
C0678222 (UMLS CUI [1,1])
C1512498 (UMLS CUI [1,2])
C0279754 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C0021044 (UMLS CUI [2,3])
C0279759 (UMLS CUI [3,1])
C0439165 (UMLS CUI [3,2])
C0021044 (UMLS CUI [3,3])
Tamoxifen Citrate | Exposure to High dose
Item
receiving treatment with tamoxifen citrate and must be eligible for exposure to higher doses
boolean
C0079589 (UMLS CUI [1])
C0332157 (UMLS CUI [2,1])
C0444956 (UMLS CUI [2,2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Exclusion Criteria | Deep Vein Thrombosis | Pulmonary Embolism
Item
no history of deep venous thrombosis or pulmonary embolism
boolean
C0680251 (UMLS CUI [1])
C0149871 (UMLS CUI [2])
C0034065 (UMLS CUI [3])
Exclusion | Endometrial Carcinoma
Item
no history of endometrial carcinoma
boolean
C2828389 (UMLS CUI [1])
C0476089 (UMLS CUI [2])
Exclusion Criteria | Vaginal Hemorrhage | Endometriosis | Endometrial Hyperplasia | Endometrial hypertrophy | Polyps
Item
no known history of vaginal bleeding, endometriosis, endometrial hyperplasia, endometrial hypertrophy, and/or polyps
boolean
C0680251 (UMLS CUI [1])
C2979982 (UMLS CUI [2])
C0014175 (UMLS CUI [3])
C0014173 (UMLS CUI [4])
C0858833 (UMLS CUI [5])
C0032584 (UMLS CUI [6])
Exclusion Criteria | Pregnancy | Breast Feeding
Item
not pregnant or nursing
boolean
C0680251 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Exclusion | Medical contraindication Tamoxifen Citrate
Item
no contraindication to tamoxifen citrate treatment
boolean
C2828389 (UMLS CUI [1])
C1301624 (UMLS CUI [2,1])
C0079589 (UMLS CUI [2,2])
Exclusion Criteria | Midazolam allergy | Hypersensitivity Dextromethorphan
Item
no known allergy to midazolam or dextromethorphan
boolean
C0680251 (UMLS CUI [1])
C0570821 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0011816 (UMLS CUI [3,2])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
ID.12
Item
see disease characteristics
boolean